[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:malignant-ureter-neoplasm":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":34,"states":35},"Malignant Ureter Neoplasm",4,[7,15,21,27],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05756569","Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology",[11],"Phase 2","RECRUITING","2026-08-26T02:16:11.347936Z","2026-05-05T02:43:29.051565Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05899361","A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest",[],"2026-08-26T02:17:09.131534Z","2026-05-05T02:43:27.595280Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT02012699","Integrated Cancer Repository for Cancer Research",[],"2026-08-26T02:16:35.654046Z","2026-05-13T02:55:06.082833Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":32,"content_modified":33},"NCT06819254","Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors",[31],"Phase 4","2026-08-26T02:16:18.872924Z","2026-05-05T02:43:29.359711Z",[],[]]